References
- Zanoni BC, Gandhi RT. Update on opportunistic infections in the era of effective antiretroviral therapy. Infect Dis Clin North Am. 2014;28:501-18.
- Hirsch HH, Kardas P, Kranz D et al The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS. 2013;121:685-727.
- Hersh BS, Popovici F, Jezek Z, et al Risk factors for HIV infection among abandoned Romanian children. AIDS. 1993;7(12):1617-24.
- World Health Organization. Global Tuberculosis Report. 20th ed. 2015. Available at: htps://apps.who.int/iris/handle/10665/191102
- Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2017. HIV Surveillance Supplemental Report 2019;24(No. 3). Available at: htp://www.cdc.gov/hiv/library/reports/ hiv-surveillance.html. Published June 2019
- Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment.Clin Infect Dis. 2010; 50(Suppl 3): S223-S230.
- Springer KL, Weinberg A. Cytomegalovirus infection in the era of HAART:fewer reactivations and more immunity. J Antimicrob Chemother. 2004;54:582-86.
- Stern-Ginossar N, Weisburd B, Michalski A, et al Decoding human cytomegalovirus. Science. 2012;338:1088–93.
- CDC. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. October 2015.
- Newcomb G, Mariuz P, Lachant D. CMV Encephalitis/Radiculitis: the difficulty in diagnosing in an intubated patient. Case Reports in Critical Care. 2019;ID 8067648.
- Cinque P, Koralnik IJ, Gerevini S, et al Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet. 2009;9:625-36.